Cyclic pyrimidin-4-carboxamides as CCR2 receptor antagonists for treatment of inflammation, asthma and COPD

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8835440
SERIAL NO

13949696

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to novel antagonists for CCR2 (CC chemokine receptor 2) and their use for providing medicaments for treating conditions and diseases, especially pulmonary diseases like asthma and COPD.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CENTREXION THERAPEUTICS CORPORATION509 SOUTH EXETER STREET BALTIMORE MD 21202

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Buettner, Frank Attenweiler, DE 29 270
Ebel, Heiner Biberach an der Riss, DE 21 281
Frattini, Sara Castelleone, IT 42 351
Giovannini, Riccardo Verona, IT 83 626
Hobbie, Silke Biberach an der Riss, DE 7 141
Hoenke, Christoph Biberach an der Riss, DE 86 855
Scheuerer, Stefan Warthausen, DE 32 308
Tielmann, Patrick Bad Soden am Taunus, DE 5 64
Trieselmann, Thomas Mettenberg, DE 32 286

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Mar 16, 2026
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00